Xinfengming Group Co., Ltd.

XSSC:603225 Stock Report

Market Cap: CN¥16.2b

Xinfengming Group Valuation

Is 603225 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

6/6

Valuation Score 6/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 603225 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 603225 (CN¥10.9) is trading below our estimate of fair value (CN¥42.41)

Significantly Below Fair Value: 603225 is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 603225?

Key metric: As 603225 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 603225. This is calculated by dividing 603225's market cap by their current earnings.
What is 603225's PE Ratio?
PE Ratio17.1x
EarningsCN¥945.06m
Market CapCN¥16.16b

Price to Earnings Ratio vs Peers

How does 603225's PE Ratio compare to its peers?

The above table shows the PE ratio for 603225 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average34.2x
002226 Anhui Jiangnan Chemical IndustryLtd
17.4x17.1%CN¥14.3b
301219 Ganzhou Tengyuan Cobalt New Material
18.9x23.7%CN¥14.3b
300568 Shenzhen Senior Technology Material
59.5x43.3%CN¥15.3b
603650 Red Avenue New Materials Group
40.9x21.3%CN¥20.3b
603225 Xinfengming Group
17.1x34.3%CN¥16.2b

Price-To-Earnings vs Peers: 603225 is good value based on its Price-To-Earnings Ratio (17.1x) compared to the peer average (34.2x).


Price to Earnings Ratio vs Industry

How does 603225's PE Ratio compare vs other companies in the CN Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
603225 17.1xIndustry Avg. 35.2xNo. of Companies42PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 603225 is good value based on its Price-To-Earnings Ratio (17.1x) compared to the CN Chemicals industry average (35.2x).


Price to Earnings Ratio vs Fair Ratio

What is 603225's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

603225 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio17.1x
Fair PE Ratio27.7x

Price-To-Earnings vs Fair Ratio: 603225 is good value based on its Price-To-Earnings Ratio (17.1x) compared to the estimated Fair Price-To-Earnings Ratio (27.7x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 603225 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCN¥10.90
CN¥15.46
+41.8%
10.8%CN¥17.22CN¥13.50n/a4
Nov ’25CN¥11.31
CN¥15.58
+37.8%
10.1%CN¥17.22CN¥13.50n/a4
Oct ’25CN¥12.66
CN¥15.93
+25.8%
7.5%CN¥17.22CN¥14.60n/a4
Sep ’25CN¥10.85
CN¥15.93
+46.8%
7.5%CN¥17.22CN¥14.60n/a4
Aug ’25CN¥13.00
CN¥16.46
+26.6%
6.5%CN¥17.22CN¥14.60n/a4
Jul ’25CN¥15.86
CN¥15.96
+0.6%
7.7%CN¥17.22CN¥14.20n/a4
Jun ’25CN¥14.44
CN¥15.96
+10.5%
7.7%CN¥17.22CN¥14.20n/a4
May ’25CN¥14.29
CN¥15.07
+5.5%
12.6%CN¥17.22CN¥12.60n/a3
Apr ’25CN¥14.84
CN¥14.00
-5.7%
8.2%CN¥15.40CN¥12.60n/a3
Mar ’25CN¥13.75
CN¥14.50
+5.5%
9.1%CN¥16.00CN¥12.60n/a4
Feb ’25CN¥11.92
CN¥14.50
+21.6%
9.1%CN¥16.00CN¥12.60n/a4
Jan ’25CN¥14.20
CN¥14.63
+3.0%
7.8%CN¥16.00CN¥13.10n/a4
Dec ’24CN¥11.97
CN¥14.13
+18.0%
5.8%CN¥15.40CN¥13.10n/a4
Nov ’24CN¥12.64
CN¥14.13
+11.7%
5.8%CN¥15.40CN¥13.10CN¥11.314
Oct ’24CN¥13.15
CN¥14.13
+7.4%
5.8%CN¥15.40CN¥13.10CN¥12.664
Sep ’24CN¥13.05
CN¥12.08
-7.4%
25.0%CN¥15.40CN¥7.60CN¥10.855
Aug ’24CN¥12.15
CN¥11.40
-6.2%
22.3%CN¥14.00CN¥7.60CN¥13.005
Jul ’24CN¥11.05
CN¥11.40
+3.2%
22.3%CN¥14.00CN¥7.60CN¥15.865
Jun ’24CN¥10.69
CN¥11.40
+6.6%
22.3%CN¥14.00CN¥7.60CN¥14.445
May ’24CN¥10.29
CN¥11.15
+8.4%
20.8%CN¥14.00CN¥7.60CN¥14.294
Apr ’24CN¥10.85
CN¥11.95
+10.1%
23.7%CN¥15.20CN¥7.60CN¥14.844
Mar ’24CN¥13.08
CN¥11.83
-9.6%
25.6%CN¥15.20CN¥7.10CN¥13.754
Feb ’24CN¥12.76
CN¥12.18
-4.6%
25.0%CN¥15.20CN¥7.10CN¥11.924
Jan ’24CN¥10.88
CN¥11.43
+5.0%
26.3%CN¥15.20CN¥7.10CN¥14.204
Dec ’23CN¥10.46
CN¥11.43
+9.2%
26.3%CN¥15.20CN¥7.10CN¥11.974
Nov ’23CN¥8.32
CN¥11.43
+37.3%
26.3%CN¥15.20CN¥7.10CN¥12.644

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies